AUTL vs MDT · rev $71.9M vs P/E 21, rev $36.36B
Autolus Therapeutics Ltd (AUTL) versus Medtronic PLC (MDT) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Medtronic PLC (MDT) is a medical devices company listed on US.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Latest reported MDT revenue for 2026-04-24 was $36.36B. Net income was $4.80B. Revenue was up 8.4% from 2025-04-25 to 2026-04-24. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
AUTL currently screens at market cap $614.8M. MDT currently screens at market cap $100.08B and trailing P/E 20.9.
Not investment advice. Open the AUTL and MDT stock pages for the full models.
Not investment advice.